Sunquest Information Systems®, a leading provider of pathology information technology, today announced it has acquired the PowerPath® Anatomic Pathology Laboratory Information System (LIS) business of Sweden-based Elekta AB. Sunquest already has leading LIS products in its Sunquest Lab and Sunquest CoPathPlus product lines. The PowerPath acquisition further solidifies Sunquest's leading position in the Anatomic Pathology LIS market.

"Sunquest's commitment to Anatomic Pathology and serving the pathologist has created a natural fit for PowerPath within the Sunquest solution suite," said Richard Atkin, CEO of Sunquest Information Systems "Together, we will have an increased critical mass and expertise to meet the needs of the pathologist in this important and growing market. I am excited to welcome the PowerPath customers into the Sunquest family." 

Dr. John Gilbertson, Associate Chief of Pathology and Director of Pathology Informatics at Massachusetts General Hospital, stated "The combination of Sunquest and PowerPath is very exciting. It will strengthen the pathology IT market and uniquely position Sunquest to produce highly advanced LIS solutions."

Chris Callahan, Vice President of Product Strategy at Sunquest, said, "This combination creates a strong market structure by combining the strengths of two successful teams under one pathology focused business." 

The transaction was completed on September 30, 2011 and integration activities are under way.

For more information about the webinar and the acquisition in general visit www.sunquestinfo.com/PPAcquisition.


About Sunquest Information Systems

Sunquest Information Systems, Inc. delivers market leading diagnostic information technology and outreach solutions designed and implemented to fulfill the business objectives of today's healthcare leaders. Headquartered in Tucson, Arizona, the company has offices in Raleigh, North Carolina; Norwich, United Kingdom; and Bangalore, India. Sunquest serves the global marketplace with reliable technology required for mission critical applications. These solutions provide the foundation to optimize the healthcare experience, deliver safe, effective, and timely patient care, expand community reach, and transform the delivery of healthcare with predictive and personalized medicine. For more information, please visit www.sunquestinfo.com or phone +1 (800) 748-0692. 

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today. Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com